Ochronosis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Ochronosis | |||
| image = [[File:Homogentisic_acid.svg|left|thumb|Chemical structure of homogentisic acid]] | |||
| caption = Chemical structure of [[homogentisic acid]], the compound that accumulates in ochronosis | |||
| field = [[Rheumatology]], [[Dermatology]] | |||
| symptoms = [[Darkening of the skin]], [[arthritis]], [[heart valve disease]] | |||
| complications = [[Joint destruction]], [[cardiovascular complications]] | |||
| onset = Typically in adulthood | |||
| duration = Chronic | |||
| causes = [[Alkaptonuria]], exposure to certain chemicals | |||
| risks = Genetic predisposition, exposure to [[phenol]] or [[hydroquinone]] | |||
| diagnosis = Clinical evaluation, [[urine test]] for homogentisic acid | |||
| differential = [[Melanosis]], [[hemochromatosis]], [[argyria]] | |||
| treatment = [[Vitamin C]], [[dietary restriction]] of phenylalanine and tyrosine, [[joint replacement surgery]] | |||
| prognosis = Variable, depends on severity and management | |||
| frequency = Rare | |||
}} | |||
[[File:Hellocker-_Pigment.JPG|Pigment deposition in ochronosis|left|thumb]] | |||
[[File:Inborn_errors_of_metabolism_of_phenylalanine_and_tyrosine.svg|Metabolic pathway of phenylalanine and tyrosine|left|thumb]] | |||
'''Ochronosis''' is a metabolic disorder characterized by the accumulation of homogentisic acid in connective tissues. It is a rare condition, often associated with [[Alkaptonuria]], a metabolic disorder that affects the body's ability to break down certain amino acids. | '''Ochronosis''' is a metabolic disorder characterized by the accumulation of homogentisic acid in connective tissues. It is a rare condition, often associated with [[Alkaptonuria]], a metabolic disorder that affects the body's ability to break down certain amino acids. | ||
== Symptoms == | == Symptoms == | ||
The most common symptom of Ochronosis is darkening of the skin, particularly in areas exposed to the sun. Other symptoms may include arthritis, heart disease, and kidney stones. The severity of symptoms can vary widely among individuals with the condition. | The most common symptom of Ochronosis is darkening of the skin, particularly in areas exposed to the sun. Other symptoms may include arthritis, heart disease, and kidney stones. The severity of symptoms can vary widely among individuals with the condition. | ||
== Causes == | == Causes == | ||
Ochronosis is caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase, which is involved in the breakdown of the amino acids phenylalanine and tyrosine. This deficiency leads to the accumulation of homogentisic acid in the body, which can cause damage to connective tissues. | Ochronosis is caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase, which is involved in the breakdown of the amino acids phenylalanine and tyrosine. This deficiency leads to the accumulation of homogentisic acid in the body, which can cause damage to connective tissues. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Ochronosis is typically based on the presence of characteristic symptoms, such as darkening of the skin and arthritis. Laboratory tests can also be used to measure the levels of homogentisic acid in the urine. | Diagnosis of Ochronosis is typically based on the presence of characteristic symptoms, such as darkening of the skin and arthritis. Laboratory tests can also be used to measure the levels of homogentisic acid in the urine. | ||
== Treatment == | == Treatment == | ||
There is currently no cure for Ochronosis, but treatment can help manage symptoms. This may include pain management for arthritis and lifestyle changes to prevent kidney stones. | There is currently no cure for Ochronosis, but treatment can help manage symptoms. This may include pain management for arthritis and lifestyle changes to prevent kidney stones. | ||
== See also == | == See also == | ||
* [[Alkaptonuria]] | * [[Alkaptonuria]] | ||
* [[Metabolic disorder]] | * [[Metabolic disorder]] | ||
* [[Connective tissue]] | * [[Connective tissue]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
[[Category:Skin conditions]] | [[Category:Skin conditions]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{stub}} | {{stub}} | ||
Latest revision as of 22:14, 9 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Ochronosis | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Darkening of the skin, arthritis, heart valve disease |
| Complications | Joint destruction, cardiovascular complications |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Alkaptonuria, exposure to certain chemicals |
| Risks | Genetic predisposition, exposure to phenol or hydroquinone |
| Diagnosis | Clinical evaluation, urine test for homogentisic acid |
| Differential diagnosis | Melanosis, hemochromatosis, argyria |
| Prevention | N/A |
| Treatment | Vitamin C, dietary restriction of phenylalanine and tyrosine, joint replacement surgery |
| Medication | N/A |
| Prognosis | Variable, depends on severity and management |
| Frequency | Rare |
| Deaths | N/A |
Ochronosis is a metabolic disorder characterized by the accumulation of homogentisic acid in connective tissues. It is a rare condition, often associated with Alkaptonuria, a metabolic disorder that affects the body's ability to break down certain amino acids.
Symptoms[edit]
The most common symptom of Ochronosis is darkening of the skin, particularly in areas exposed to the sun. Other symptoms may include arthritis, heart disease, and kidney stones. The severity of symptoms can vary widely among individuals with the condition.
Causes[edit]
Ochronosis is caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase, which is involved in the breakdown of the amino acids phenylalanine and tyrosine. This deficiency leads to the accumulation of homogentisic acid in the body, which can cause damage to connective tissues.
Diagnosis[edit]
Diagnosis of Ochronosis is typically based on the presence of characteristic symptoms, such as darkening of the skin and arthritis. Laboratory tests can also be used to measure the levels of homogentisic acid in the urine.
Treatment[edit]
There is currently no cure for Ochronosis, but treatment can help manage symptoms. This may include pain management for arthritis and lifestyle changes to prevent kidney stones.
